|
Strides Pharma Science Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
6003.02 Cr.
|
P/BV
|
2.64
|
Book Value (Rs.)
|
246.48
|
|
52 Week High/Low (Rs.)
|
1675/513
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
09/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.38
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 1153.67 | 1201.11 | 1087.51 | 1084.04 | 1037.67 |
| Total Income From Operations | 1153.67 | 1201.11 | 1087.51 | 1084.04 | 1037.67 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 476.58 | 448.85 | 364.21 | 353.84 | 375.13 |
| Purchase of Traded Goods | 133.77 | 55.33 | 79.44 | 112.64 | 50.66 |
| Increase/Decrease in Stocks | -130.23 | -6.26 | -23.21 | -50.25 | -4.55 |
| Employees Cost | 215.64 | 219.41 | 212.17 | 199.17 | 184.49 |
| Depreciation | 48.42 | 50.52 | 48.59 | 49.76 | 51.23 |
| Other Expenses | 247.59 | 247.97 | 237.91 | 238.91 | 238.12 |
| Total Expenses | 991.78 | 1015.83 | 919.12 | 904.06 | 895.09 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 161.89 | 185.28 | 168.39 | 179.97 | 142.58 |
| Other Income | 5.62 | 28.41 | 12.72 | -13.55 | 8.75 |
| P/L Before Interest, Excpt. Items & Tax | 167.50 | 213.69 | 181.10 | 166.43 | 151.34 |
| Interest | 52.18 | 82.15 | 80.39 | 80.16 | 79.28 |
| P/L Before Exceptional Items & Tax | 115.32 | 131.55 | 100.71 | 86.27 | 72.05 |
| Exceptional Items | -2.43 | -3.87 | -3.74 | -8.07 | -10.07 |
| P/L Before Tax | 112.89 | 127.67 | 96.98 | 78.20 | 61.99 |
| Tax | 23.81 | 21.20 | 16.86 | 19.25 | 10.10 |
| P/L After Tax from Ordinary Activities | 89.09 | 106.47 | 80.12 | 58.95 | 51.88 |
| Extra Ordinary Item | 0.00 | 0.00 | 0.00 | 0.07 | 54.15 |
| Net Profit/Loss For the Period | 89.09 | 106.47 | 80.12 | 59.02 | 106.03 |
| Minority Interest | -2.09 | -0.43 | 1.89 | 7.73 | -4.39 |
| Share Of P/L Of Associates | 0.95 | -12.81 | -11.80 | -48.58 | -51.97 |
| Net P/L After Minority Interest & Share Of Associates | 87.95 | 93.23 | 70.20 | 18.18 | 49.67 |
| | | | | | |
| Equity Share Capital | 92.16 | 91.96 | 91.90 | 91.90 | 91.89 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 9.56 | 10.14 | 7.64 | 1.98 | 5.43 |
| Diluted EPS (Rs.) | 9.55 | 10.12 | 7.62 | 1.97 | 5.42 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 9.56 | 10.14 | 7.64 | 1.98 | 5.43 |
| Diluted EPS (Rs.) | 9.55 | 10.12 | 7.62 | 1.97 | 5.42 |
| | | | | | |
| PBITOE Margin (%) | 14.03 | 15.42 | 15.48 | 16.60 | 13.74 |
| PBTE Margin (%) | 9.99 | 10.95 | 9.26 | 7.95 | 6.94 |
| PBT Margin (%) | 9.78 | 10.62 | 8.91 | 7.21 | 5.97 |
| PAT Margin (%) | 7.72 | 8.86 | 7.36 | 5.44 | 10.21 |
| PAT After MI And SOA Margin (%) | 7.62 | 7.76 | 6.45 | 1.67 | 4.78 |
